1-3 of 3
Long Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Roflumilast-Mediated Phosphodiesterase 4D Inhibition Reverses Diabetes-Associated Cardiac Dysfunction and Remodeling: Effects Beyond Glucose Lowering

Rui Xu, Jing Fu, Yuting Hu, Xiaoyan Yang, Xiang Tao, Long Chen, Kai Huang, Qin Fu
Journal: Diabetes
Diabetes 2022;71(8):1660–1678
https://doi.org/10.2337/db21-0898
Published: 21 August 2022
View articletitled, Roflumilast-Mediated Phosphodiesterase 4D Inhibition Reverses Diabetes-Associated Cardiac Dysfunction and Remodeling: Effects Beyond Glucose Lowering
Open the PDF for Roflumilast-Mediated Phosphodiesterase 4D Inhibition Reverses Diabetes-Associated Cardiac Dysfunction and Remodeling: Effects Beyond Glucose Lowering in another window
Journal Articles

Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy

Xin Tan, Lizhi Hu, Zhiping Shu, Long Chen, Xiangrao Li, Meng Du, Dan Sun, Xiaoxiang Mao, Shan Deng, Kai Huang, Fengxiao Zhang
Journal: Diabetes
Diabetes 2019;68(11):2063–2073
https://doi.org/10.2337/db18-1231
Published: 22 August 2019
View articletitled, Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy
Open the PDF for Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy in another window
Includes: Supplementary data
Journal Articles

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

Jing Xu, David J. Lloyd, Clarence Hale, Shanaka Stanislaus, Michelle Chen, Glenn Sivits, Steven Vonderfecht, Randy Hecht, Yue-Sheng Li, Richard A. Lindberg, Jin-Long Chen, Dae Young Jung, Zhiyou Zhang, Hwi-Jin Ko, Jason K. Kim, Murielle M. Véniant
Journal: Diabetes
Diabetes 2009;58(1):250–259
https://doi.org/10.2337/db08-0392
Published: 01 January 2009
View articletitled, Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Open the PDF for Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice in another window
Includes: Supplementary data